Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population

Vaccine. 2006 Mar 15;24(12):2043-8. doi: 10.1016/j.vaccine.2005.11.024. Epub 2005 Nov 28.

Abstract

German adolescents (n=123) without previous pertussis vaccination, no history of pertussis and low IgG-anti-pertussis-toxin (PT) levels received one dose of the Tdap vaccine Boostrix. Blood samples were taken before, and 5-12 days and 29-49 days after vaccination. IgG- and IgA-anti-PT, IgG- and IgA-anti filamentous hemagglutinin, IgG-anti-pertactin, IgG-anti-tetanus-toxin, and IgG-anti-diphtheria-toxin were measured by ELISA. 88.6% of subjects had an immune response to PT, and all vaccinees had an immune response to at least one pertussis antigen 29-49 days after vaccination. IgA-anti-PT and IgA-anti-FHA responses were found in 43 and 81% of subjects, respectively. This study shows that in unvaccinated German adolescents pertussis immunity can be achieved by a single dose of Tdap.

Publication types

  • Multicenter Study

MeSH terms

  • Adolescent
  • Antibodies, Bacterial / blood
  • Antigens, Bacterial / administration & dosage*
  • Antigens, Bacterial / immunology
  • Bordetella pertussis / chemistry*
  • Bordetella pertussis / immunology
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / administration & dosage
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / immunology*
  • Female
  • Humans
  • Immunization Schedule
  • Immunoglobulin G / blood
  • Male
  • Whooping Cough / epidemiology
  • Whooping Cough / immunology
  • Whooping Cough / prevention & control*

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Diphtheria-Tetanus-acellular Pertussis Vaccines
  • Immunoglobulin G